2.04
+0.06(+3.03%)
Currency In USD
| Previous Close | 1.98 |
| Open | 2.01 |
| Day High | 2.12 |
| Day Low | 1.96 |
| 52-Week High | 3.03 |
| 52-Week Low | 0.83 |
| Volume | 4.51M |
| Average Volume | 3.78M |
| Market Cap | 147.28M |
| PE | -0.88 |
| EPS | -2.32 |
| Moving Average 50 Days | 1.38 |
| Moving Average 200 Days | 1.42 |
| Change | 0.06 |
If you invested $1000 in Fractyl Health, Inc. Common Stock (GUTS) since IPO date, it would be worth $158.75 as of December 07, 2025 at a share price of $2.04. Whereas If you bought $1000 worth of Fractyl Health, Inc. Common Stock (GUTS) shares 6 months ago, it would be worth $708.33 as of December 07, 2025 at a share price of $2.04.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Fractyl Health Reports Positive 6-Month REVEAL-1 Open-Label Results Showing Sustained Post-GLP-1 Weight Maintenance After a Single Revita® Procedure
GlobeNewswire Inc.
Dec 02, 2025 12:00 PM GMT
Participants who lost 24% total body weight (>50 lbs.) on GLP-1 drugs maintained stable weight 6 months after GLP-1 discontinuation and single Revita treatment 1.5% mean weight change observed with Revita (n=17); published third-party studies after G
Fractyl Health to Participate in the 8th Annual Evercore Healthcare Conference
GlobeNewswire Inc.
Dec 01, 2025 12:00 PM GMT
BURLINGTON, Mass., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the Company or Fractyl), a metabolic therapeutics company focused on pattern-breaking approaches that treat root causes of obesity and type 2 diabetes (T2D),
Fractyl Health to Report Third Quarter 2025 Financial Results and Provide Business Updates on November 12, 2025
GlobeNewswire Inc.
Nov 05, 2025 12:00 PM GMT
BURLINGTON, Mass., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the Company), a metabolic therapeutics company focused on pattern-breaking approaches to treat the root causes of obesity and type 2 diabetes (T2D), today ann